Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Toshikatsu Kawasaki"'
Autor:
Yuma Shibutani, Kazuko Tajiri, Shinya Suzuki, Tomohiro Enokida, Atsunobu Sagara, Susumu Okano, Takao Fujisawa, Fumiaki Sato, Tetsuro Yumoto, Motohiko Sano, Toshikatsu Kawasaki, Makoto Tahara
Publikováno v:
Cancer Medicine, Vol 12, Iss 22, Pp 20773-20782 (2023)
Abstract Background Hypertension is the most frequently occurring adverse event of lenvatinib, recognized relatively early in its course. However, the trend in blood pressure after the initiation of lenvatinib and the outcomes with antihypertensive t
Externí odkaz:
https://doaj.org/article/25332373f7da40b29df12ef342640d17
Autor:
Ryota Tashiro, Hitoshi Kawazoe, Kanako Mamishin, Keisuke Seto, Ryoko Udagawa, Yoshimasa Saito, Hironobu Hashimoto, Tatsunori Shimoi, Kan Yonemori, Masahito Yonemura, Hiroyuki Terakado, Takahiro Nishimura, Toshikatsu Kawasaki, Tetsuya Furukawa, Tomonori Nakamura
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract The standard treatment for platinum-sensitive relapsed ovarian cancer (PSROC) is platinum-based chemotherapy followed by olaparib monotherapy. A retrospective study was conducted to identify factors affecting the survival of patients with PS
Externí odkaz:
https://doaj.org/article/23d39bf62fc4468f8b2f7a2bcc990961
Autor:
Kaede Baba, Megumi Kawamoto, Kanako Mamishin, Mao Uematsu, Hikari Kiyohara, Akira Hirota, Nobuyuki Takahashi, Misao Fukuda, Shota Kusuhara, Hiromichi Nakajima, Chikako Funasaka, Takehiro Nakao, Chihiro Kondoh, Kenichi Harano, Nobuaki Matsubara, Yoichi Naito, Ako Hosono, Toshikatsu Kawasaki, Toru Mukohara
Publikováno v:
Cancer Medicine, Vol 12, Iss 11, Pp 12095-12105 (2023)
Abstract Background Since it was first reported in December 2019, coronavirus disease 2019 (COVID‐19) spread rapidly across the globe resulting in a pandemic. As of August 2022, seven outbreak peaks have been confirmed in Tokyo, and the numbers of
Externí odkaz:
https://doaj.org/article/c0255b117bae403e9d5e854df13ba152
Autor:
Ai Horinouchi, Tomohiro Enokida, Shinya Suzuki, Hayato Kamata, Asumi Kaneko, Chihiro Matsuyama, Takao Fujisawa, Yuri Ueda, Kazue Ito, Susumu Okano, Toshikatsu Kawasaki, Makoto Tahara
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundPersistent opioid use frequently leads to substantial negative impacts on quality of life, and as the outlook for numerous cancer types continues to improve, these complications become increasingly crucial. It is essential to acknowledge th
Externí odkaz:
https://doaj.org/article/f96c0f2c26734cdeb24e1ec8e8880719
Autor:
Hidetaka Suzuki, Shuichi Mitsunaga, Masafumi Ikeda, Takao Aoyama, Kazumi Yoshizawa, Masayuki Yamaguchi, Masami Suzuki, Minoru Narita, Toshikatsu Kawasaki, Atsushi Ochiai
Publikováno v:
Cancer Medicine, Vol 11, Iss 24, Pp 5001-5012 (2022)
Abstract Background Nerve invasion (N‐inv) is an important prognostic factor in pancreatic ductal adenocarcinoma (PDAC). Elucidation of circulating N‐inv stimulators could provide deeper insights and novel perspectives for PDAC therapy. The inter
Externí odkaz:
https://doaj.org/article/efd5f3e361854948abe6a02cbdc5972c
Autor:
Daisuke Ueki, Shinya Suzuki, Takahiro Ohta, Akira Shinohara, Yasukata Ohashi, Daisuke Konuma, Yasuaki Ryushima, Ryoko Udagawa, Hironori Motoshige, Masahiro Ieoka, Akihiro Taji, Yuuki Kogure, Mikako Hiraike, Miyuki Uoi, Kazuhiko Ino, Toshikatsu Kawasaki, Masakazu Yamaguchi
Publikováno v:
Pharmacy, Vol 12, Iss 1, p 1 (2023)
Although prescription review is an important role for pharmacists in anticancer drug therapy, there are no guidelines in Japan that specify what pharmacists should check for in chemotherapy regimens. This prospective multicenter survey aimed to inves
Externí odkaz:
https://doaj.org/article/affda06035f2417e91f2adfbc852a57e
Autor:
Yuma Shibutani, Shinya Suzuki, Atsunobu Sagara, Tomohiro Enokida, Susumu Okano, Takao Fujisawa, Fumiaki Sato, Tetsuro Yumoto, Motohiko Sano, Toshikatsu Kawasaki, Makoto Tahara
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundProteinuria is the most frequent adverse event of lenvatinib use. However, the association between lenvatinib-induced proteinuria and renal dysfunction remains unclear.MethodsWe retrospectively reviewed medical records of patients with thyr
Externí odkaz:
https://doaj.org/article/bf2ddac6f23a4c23873e4afe40272e95
Autor:
Ryota Tashiro, Hitoshi Kawazoe, Kanako Mamishin, Keisuke Seto, Ryoko Udagawa, Yoshimasa Saito, Hironobu Hashimoto, Tatsunori Shimoi, Kan Yonemori, Masahito Yonemura, Hiroyuki Terakado, Toshikatsu Kawasaki, Tetsuya Furukawa, Tomonori Nakamura
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundOlaparib-induced anemia is a frequently occurring complication in patients with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer and is associated with a marked deterioration in patients’ health-related quality
Externí odkaz:
https://doaj.org/article/4a7f9c552d79479c93a8989899915f64
Autor:
Chikako Funasaka, Yoichi Naito, Shota Kusuhara, Takehiro Nakao, Yoko Fukasawa, Kanako Mamishin, Ayumi Komuro, Mashiro Okunaka, Chihiro Kondoh, Kenichi Harano, Takahiro Kogawa, Nobuaki Matsubara, Ako Hosono, Toshikatsu Kawasaki, Toru Mukohara
Publikováno v:
Breast, Vol 58, Iss , Pp 50-56 (2021)
Background: Visceral crisis in metastatic breast cancer (MBC) is defined as severe organ dysfunction requiring rapidly efficacious therapy. Although weekly paclitaxel plus bevacizumab (wPTX + BV) achieves a high response rate in human epidermal growt
Externí odkaz:
https://doaj.org/article/1ee0cb78f98046edb5ecc170618af845
Autor:
Kaho Miura, Yoshiyuki Sano, Seiji Niho, Kenji Kawasumi, Nobuo Mochizuki, Kiyotaka Yoh, Shingo Matsumoto, Yoshitaka Zenke, Takaya Ikeda, Kaname Nosaki, Keisuke Kirita, Hibiki Udagawa, Koichi Goto, Toshikatsu Kawasaki, Kazuhiko Hanada
Publikováno v:
Thoracic Cancer, Vol 12, Iss 13, Pp 1983-1994 (2021)
Abstract Background It has recently been suggested that concomitant medication may affect the clinical outcome of patients treated with immune checkpoint inhibitors (ICIs). However, only a few studies on the impact of concomitant medication on immune
Externí odkaz:
https://doaj.org/article/c2b2b23ff3964b8ba27171c6dc3821fb